Cargando…

Stroke risk stratification in atrial fibrillation: a review of common risk factors

Atrial Fibrillation (AF) has become a major global health concern being the most common sustained arrhythmia in clinical practice. Risk factors for AF include congestive heart failure, hypertension, increasing age and diabetes. Many of these factors also increase the risk for thromboembolism and isc...

Descripción completa

Detalles Bibliográficos
Autores principales: Oladiran, Oreoluwa, Nwosu, Ifeanyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484493/
https://www.ncbi.nlm.nih.gov/pubmed/31044042
http://dx.doi.org/10.1080/20009666.2019.1593781
_version_ 1783414125780533248
author Oladiran, Oreoluwa
Nwosu, Ifeanyi
author_facet Oladiran, Oreoluwa
Nwosu, Ifeanyi
author_sort Oladiran, Oreoluwa
collection PubMed
description Atrial Fibrillation (AF) has become a major global health concern being the most common sustained arrhythmia in clinical practice. Risk factors for AF include congestive heart failure, hypertension, increasing age and diabetes. Many of these factors also increase the risk for thromboembolism and ischemic stroke in AF patients. Great efforts have been made from the latter part of the 20(th) century towards developing an ideal stroke risk stratification tool in AF with the aim of reducing the incidence of stroke in AF patients and the limiting unnecessary use of thromboprophylaxis. The thromboembolic risks posed by AF with valvular heart disease are an important subgroup that contributes to a significant proportion of stroke in AF patients globally. We review the evolution of stroke risk stratification and summarize the guidelines for stroke prevention in non-valvular AF as well as AF with valvular heart disease, and the most recent recommendations on stroke prevention in AF patients. Abbreviations: AF: Atrial Fibrillation; ACS: Acute Coronary Syndrome; CAD: Coronary Artery Disease; CCF: Congestive Cardiac Failure; DM: Diabetes Mellitus; EHRA: Evaluated Heartvalves, Rheumatic or Artificial; ICH: Intracranial Hemorrhage; NOACs: Novel Oral Anticoagulants; OAC: Oral Anticoagulants; PAD: Peripheral Arterial Disease ; TIA: Transient Ischemic Attack; VHD: Valvular Heart Disease.
format Online
Article
Text
id pubmed-6484493
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-64844932019-05-01 Stroke risk stratification in atrial fibrillation: a review of common risk factors Oladiran, Oreoluwa Nwosu, Ifeanyi J Community Hosp Intern Med Perspect Review Article Atrial Fibrillation (AF) has become a major global health concern being the most common sustained arrhythmia in clinical practice. Risk factors for AF include congestive heart failure, hypertension, increasing age and diabetes. Many of these factors also increase the risk for thromboembolism and ischemic stroke in AF patients. Great efforts have been made from the latter part of the 20(th) century towards developing an ideal stroke risk stratification tool in AF with the aim of reducing the incidence of stroke in AF patients and the limiting unnecessary use of thromboprophylaxis. The thromboembolic risks posed by AF with valvular heart disease are an important subgroup that contributes to a significant proportion of stroke in AF patients globally. We review the evolution of stroke risk stratification and summarize the guidelines for stroke prevention in non-valvular AF as well as AF with valvular heart disease, and the most recent recommendations on stroke prevention in AF patients. Abbreviations: AF: Atrial Fibrillation; ACS: Acute Coronary Syndrome; CAD: Coronary Artery Disease; CCF: Congestive Cardiac Failure; DM: Diabetes Mellitus; EHRA: Evaluated Heartvalves, Rheumatic or Artificial; ICH: Intracranial Hemorrhage; NOACs: Novel Oral Anticoagulants; OAC: Oral Anticoagulants; PAD: Peripheral Arterial Disease ; TIA: Transient Ischemic Attack; VHD: Valvular Heart Disease. Taylor & Francis 2019-04-12 /pmc/articles/PMC6484493/ /pubmed/31044042 http://dx.doi.org/10.1080/20009666.2019.1593781 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Oladiran, Oreoluwa
Nwosu, Ifeanyi
Stroke risk stratification in atrial fibrillation: a review of common risk factors
title Stroke risk stratification in atrial fibrillation: a review of common risk factors
title_full Stroke risk stratification in atrial fibrillation: a review of common risk factors
title_fullStr Stroke risk stratification in atrial fibrillation: a review of common risk factors
title_full_unstemmed Stroke risk stratification in atrial fibrillation: a review of common risk factors
title_short Stroke risk stratification in atrial fibrillation: a review of common risk factors
title_sort stroke risk stratification in atrial fibrillation: a review of common risk factors
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484493/
https://www.ncbi.nlm.nih.gov/pubmed/31044042
http://dx.doi.org/10.1080/20009666.2019.1593781
work_keys_str_mv AT oladiranoreoluwa strokeriskstratificationinatrialfibrillationareviewofcommonriskfactors
AT nwosuifeanyi strokeriskstratificationinatrialfibrillationareviewofcommonriskfactors